Punch & Associates Investment Management’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-436,500
Closed -$2.27M 241
2023
Q1
$2.27M Sell
436,500
-61,000
-12% -$438K 0.15% 142
2022
Q4
$3.69M Buy
497,500
+195,160
+65% +$1.76M 0.24% 131
2022
Q3
$3.79M Buy
302,340
+117,340
+63% +$1.4M 0.26% 128
2022
Q2
$1.42M Buy
185,000
+105,000
+131% +$881K 0.1% 161
2022
Q1
$810K Buy
+80,000
New +$731K 0.05% 174

Other funds holding SRTS

Punch & Associates Investment Management's SRTS Position: Q2 2023 in Review

Punch & Associates Investment Management sold out of Sensus Healthcare (SRTS) in Q2 2023, closing a stake of 436,500 shares — an estimated $2.27M sold.

Punch & Associates Investment Management first reported a position in SRTS in Q1 2022 and held it in 5 quarters. The position peaked at $3.79M in Q3 2022. 49 funds tracked by Wall St. Rank hold SRTS as of Q2 2023.

  • Punch & Associates Investment Management reported no remaining Sensus Healthcare position as of Q2 2023 after selling out during the quarter.
  • Punch & Associates Investment Management sold 436,500 Sensus Healthcare shares in Q2 2023, an estimated $2.27M.
  • Punch & Associates Investment Management first reported a position in Sensus Healthcare in Q1 2022 and held it in 5 quarters.
  • Punch & Associates Investment Management's Sensus Healthcare position peaked at $3.79M in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2023.

Based on Punch & Associates Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.